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To all women worldwide who suffer from endometriosis, the painful condition not always 
recognized or believed                                                                                                                                         
 
 
 
 
 
 
 
 
                                                         Don’t focus on the problem alone, look for the solution  
  
 
 
 
 
  
ABSTRACT 
Background: Endometriosis is a common gynecological condition with a substantial 
economic burden on the society. It is known that both genetic and environmental factors are 
contributing to the phenotypic development of the disease but the mechanisms of their 
coexistence in the disease process are poorly understood. Endometriosis is assumed to be 
caused by multiple genes, however, no candidate gene has been found so far to be associated 
with endometriosis. Further, genome-wide association studies have found several loci to be 
associated with endometriosis, but the particular genetic variants have not been described yet. 
Thus, little is known about heritability so far. Furthermore, the possible types of 
environmental factors are yet to be investigated. Associations between reproductive, lifestyle 
factors and endometriosis have been investigated, while the significance of these factors in 
the development of endometriosis is not well established.   
 
Methods: The study population comprised of all female twins in the Swedish twin registry, 
aged 20–65 years in Study I and II and aged 20–60 years in Study III. Study I estimated the 
prevalence of endometriosis and the influence of heredity on occurrence of endometriosis by 
genetic modeling. The associations between reproductive, lifestyle factors and endometriosis 
were investigated in Study II. In Study III we examined the validity of self-reported 
endometriosis and endometriosis-related questions with the data on endometriosis in the in-
patient registry (IPR). 
 
Results: The prevalence of endometriosis among Swedish twins was estimated to be 4.3%. 
The heritability of endometriosis was 47% and the remaining effect of 53% was explained by 
unique environment. A history of late age at menarche and higher parity with two or more 
children showed an inverse association with the risk to develop endometriosis, while, 
infertility was strongly associated with endometriosis. Women who used oral contraceptive 
pills solely for contraception showed no significant association with endometriosis. Body 
mass index, level of education, coffee consumption, smoking and alcohol consumption did 
not show any association with endometriosis. Good agreement was found between self-
reported endometriosis and data on endometriosis in IPR and the predictive ability of self-
reported endometriosis having an endometriosis diagnosis in IPR was increased when there 
was information about age and infertility. 
 
Conclusions: In conclusion, the collective findings from this thesis suggest a strong genetic 
influence on phenotypic manifestation of endometriosis. Infertility and endometriosis are 
strongly associated with each other, however, the causality and whether they have a common 
genetic origin remains unknown. Self-reported data on endometriosis may be useful in 
clinical and epidemiological studies. 
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1 INTRODUCTION 
Endometriosis is a chronic, inflammatory and estrogen-dependent disease (1). The prevalence 
of endometriosis is not exactly known since the disease requires surgical confirmation, but it 
is estimated to be 2-10% in women of reproductive age and up to 50% among infertile 
women (1-3).  
The exact etiology and pathogenesis of endometriosis remain largely unknown. However, it 
is suggested to be a complex multifactorial disease where both genes and environment 
contribute to the development of the disease (3-8). 
Studies have indicated familial accumulation (5, 6, 8) and there is a greater risk, 3–15 times 
in first degree relatives of women with endometriosis compared to healthy controls (4, 7-9).  
Based on these findings researchers have performed studies to identify potential candidate 
genes and also to identify susceptibility loci using Genome-Wide Association Studies 
(GWAS) approach in populations of European descent (10, 11) and in Japanese populations 
(12, 13).  
A number of menstrual and reproductive factors are considered to be associated with 
endometriosis (14-21). Environmental and lifestyle factors are also suggested as risk factors 
or markers of risk for endometriosis (22-27). 
Questionnaires with self-reported diagnosis are often used for epidemiological studies. 
Validation of self-reported diagnosis with medical records or in-patient registries is important 
especially for endometriosis where surgery is required for diagnosis. Good agreement has 
been shown between self-reported data and in-patient registry data on other questions than 
endometriosis (28, 29). To our knowledge, there is no study published on validation of self-
reported endometriosis and endometriosis-related questionnaire with in-patient registry data.  
Since endometriosis is a common gynecological disease with high prevalence and with huge 
economic burden on society that is theoretically estimated to be between 0.8 million and 12.5 
billion euros yearly (30). Increased knowledge about the etiology, pathology and potential 
risk factors or markers of risk for endometriosis is important to be able to reduce the 
morbidity among those affected. This could improve the quality of life and as well as to 
reduce the financial burden.
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2 BACKGROUND 
 
2.1 ENDOMETRIOSIS 
 
2.1.1 Definition and epidemiology 
 
Endometriosis is defined by the presence of endometrial glands and stroma in sites outside 
the uterus and adenomyosis is defined by the presence of endometrial glands and stroma 
within the muscle wall of the uterus. Endometriosis can also cause cysts in the ovaries, called 
endometrioma or “chocolate cysts”. The prevalence of endometriosis is estimated to be 2-
10% among fertile women. Of all women with endometriosis 2-4% is estimated to affect 
postmenopausal women, probably due to exogen estrogen therapy (31, 32). The incidence of 
endometriosis has been suggested to be higher in Asian than in Caucasian women and lowest 
in African women. These results are uncertain, due to confounding factors such as 
socioeconomic status and the different availability of health care facilities (33, 34).  
 
2.1.2 History of endometriosis 
 
Endometriosis is often believed to be a disease of the modern, industrialized society of the 
1900s.  The increased occurrence has been attributed to industrial or commercial 
environmental pollutants (such as dioxins with estrogen-like properties), or postponement of 
childbearing to later age. However, symptoms associated with endometriosis have been 
amply documented in medical texts more than 4,000 years ago (35).   
Historically the symptoms of endometriosis were poorly understood since it is an internal 
disease. Its recognition as a disease by the medical profession came about in 1860 when a 
detailed monograph was published by Austrian pathologist, Carl von Rokitansky (36).  In 
1908, the surgeon Thomas Cullen described the complete morphological and clinical picture 
of endometriosis and adenomyosis for the first time.  In 1921, J.A Sampson first reported on 
ovarian endometrioma which he described as perforating hemorrhagic (chocolate) cysts of 
the ovary (37). In 1927, he formally described endometriosis when he presented a paper 
identifying 13 patients in whom the presence of endometrial tissue was observed during 
abdominal surgery (38). Sampson also provided the first theory of retrograde menstruation as 
the main etiological factor in the development of the disease. 
With the advent of laparoscopy, it became evident that many of the macroscopic appearances 
of active endometriosis, (67-71% of cases) were found to be endometrial glands and stroma 
on histological inspection of peritoneal biopsies (39). 
Surgical treatment of endometriosis commenced in the early 1900's, after advancements in 
anesthesia had rendered surgery relatively safe. Conservative surgery was introduced in 
1960s and there was development in the use of specialized instruments and laser in 1980s. 
Hormone therapies were not available until the mid-1900s. Large dose estrogen was the first 
line of therapy used in 1948 by Karnaky (40), but the negative side effects were severe and 
the success rates relatively low. Combined estrogen-progestogen (pseudo-pregnancy) 
treatment was introduced by Kistner in 1958 (41). The synthetic androgen Danazol was 
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introduced in 1976 and in late 1980s gonadotrophin releasing hormone (GnRH) was 
introduced. 
 
2.1.3 Pathogenesis 
 
The etiology and pathogenesis of endometriosis have not been fully understood, but different 
theories have been proposed. It is likely that several theories are involved for all aspects of 
the disease. It is described as a heterogeneous disease with different manifestations like 
peritoneal, deeply infiltrating, ovarian and extrapelvic endometriosis and each manifestation 
may have its’ own etiology.   
 
The embryonic remnants theory 
 
In the late 19th century, von Recklinghausen presented the embryonic remnants theory which 
proposed an activation of remnants from the Mϋllerian tract that later developed to 
endometriosis in the pelvic region (42, 43). This mechanism possibly explains endometriosis 
of the recto-vaginal septum (44). 
 
Implantation theory 
 
Sampson proposed in 1927 that the endometrial effluent is disseminated into the abdominal 
cavity by retrograde transport through the fallopian tubes at the time of menstruation  (45). 
This theory is widely accepted and explains why endometriosis is extremely unusual in 
women with amenorrhea. Perhaps, the strongest argument against this explanation is that 
retrograde menstruation occurs in the majority of women, while endometriosis develops only 
in 2-10 percent. Obviously, other factors also play a role in pathogenesis (31, 45, 46). 
Superficial lesions of endometriosis in peritoneal, serosal and ovarian surfaces can be 
explained by this theory.  
 
The lymphatic and vascular metastatic theory 
 
The lymphatic and vascular metastatic theory suggests a dissemination of endometrial cells 
through lymphatic and blood vessels and explains the development of endometriosis outside 
the pelvis as in the lungs, pleura and kidneys as well as in other distant places like skeletal 
muscle, peripheral nerves and brain (47-49).  
 
Metaplastic transformation theory 
 
Another important theory proposed that endometriosis develops through the metaplastic 
transformation of coelomic cells lining the pelvic peritoneum, called coelomic metaplasia 
(50). This theory is supported by the fact that both endometrial and peritoneal cells are 
derived from the same embryonal structure (coelomic-wall epithelium) (31). Ovarian 
endometriosis and possibly even rectovaginal endometriosis occur due to metaplastic 
transformation (51, 52). The occurrence of endometriosis in women with Mayer- Rokitansky-
Kϋster-Hauser Syndrome, who do not have a uterus, could be explained by this theory (53).  
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Theory of immunology, inflammation and endocrine disruption 
 
A defect in the immune system is considered to be the basis for some women suffering from 
endometriosis (54, 55). Macrophages are believed to play a central role in regulating both 
cellular and humoral inflammatory activity since they can synthesize and release a variety of 
cytokines and growth factors (56). The natural killer cells in women with endometriosis 
express for instance a lower cytotoxic activity compared to healthy women, which could 
contribute to a lower ability to identify and destroy displaced endometrial fragments (57).  
Further, it is believed that endometrial fragments can escape detection by releasing adhesion 
molecules including soluble intercellular adhesion molecule-1(sICAM-1). Cytokines such as 
tumor necrosis factor alfa  (TNF-α), interleukin IL-1, IL-6, IL-8, IL-18 (58), regulated on 
activation normal T cell expressed and secreted (RANTES) (59), transforming growth factor 
beta  (TGF-β) and vascular endothelial growth factor (VEGF)  are also considered to 
contribute to the development of endometriosis. 
 
Subtypes of endometriosis 
 
The main theories explaining different subtypes of endometriosis are described below. 
 
Peritoneal endometriosis 
 
Peritoneal endometriosis is superficial lesions presented over the serosal, ovarian and 
peritoneal surfaces. These lesions are partly explained by Sampson’s theory of retrograde 
menstruation (45).  
 
Deeply infiltrating disease 
 
Deep infiltrating disease of the rectovaginal septum was first proposed by Sampson in 1922 
(60). Three hypotheses have been described later. It was first suggested by Cullen that lower 
uterine adenomyosis directly extends to the rectovaginal septum (43). Further, Vercellini et 
al., suggested that lesions originate from secondary infiltration of peritoneal endometriosis 
(61). The third hypothesis suggests that lesions probably arise from metaplastic process of 
mϋllerian rest and have a different entity to peritoneal lesions (51). 
 
Ovarian endometrioma 
 
Three theories have been proposed so far. The first hypothesis by Hughesdon in 1957 
suggested that superficial lesions on the ovarian cortex become inverted and invaginated (62).  
Another hypothesis is that the lesions are derived from functional ovarian cysts (63, 64). The 
third hypothesis is the metaplastic process of the mesothelial inclusions resulting in the 
formation of endometrioma (50, 53). 
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2.1.4 Clinical findings and diagnosis  
 
Endometriotic lesions are mainly located in the sacrouterine ligaments, the ovaries, the 
vesico-uterine pouch and the pouch of Douglas, while the cells can also implant on the wall 
of the bladder and the intestines. Lesions respond to steroid hormones and usually bleed 
monthly at the time of menstruation. Further, an inflammatory reaction occurs leading to 
pain, adhesions and fibrosis. The disease can spread superficially or can invade the deeper 
tissues like recto-vaginal septum.  
Painful menstruations (dysmenorrhea), pain during intercourse (dyspareunia) (65-68) and 
chronic pain (68, 69)  in the lower abdomen and pelvic region are the main symptoms of 
endometriosis. In rare cases endometriosis can grow through the wall of the bladder or bowel, 
causing hematuria or melena at the time of menstruation. Infertility is often associated with 
endometriosis (2, 68). There is no clear link between endometriosis severity or localization 
and subfertility/infertility (70). It has been discussed that adhesion formation and altered 
motility of fallopian tube (71), phagocytosis of sperm (72), ovulatory dysfunction, defects in 
fertilization or implantation and embryo toxicity are causal (73). 
The prediction and diagnosis of endometriosis based on symptoms alone may be weak and 
incomplete. Clinical examination helps in diagnosis and treatment of the disease. 
Examination includes inspection of the vagina using a speculum, bimanual and rectovaginal 
palpation (74, 75). One should also inspect posterior fornix of the vaginal wall (74).  
Immunological biomarkers such as CA125 in plasma, urine or serum are not recommended 
for diagnosis of endometriosis (76). Transvaginal or transrectal ultrasound or Magnet 
Resonance Imaging (MRI) is better than clinical examination in diagnosis of endometrioma 
and/or deep endometriosis (74, 75). However, it is not possible to detect endometriosis 
lesions of less than 3 mm with the help of MRI (77, 78).  Transvaginal sonography is a useful 
tool for the identification of rectal endometriosis (79) and ovarian endometrioma (80). MRI is 
a good method for diagnosis of endometriosis in the ovaries (81) and can detect and 
characterize different types of deep endometriosis (75). It is important to exclude ureter, 
bladder and bowel involvement by additional imaging.  
Diagnostic laparoscopy is beneficial for ruling out endometriosis in women with signs and 
symptoms of the disease (82). Laparoscopy with or without histological verification has been 
widely used for the diagnosis of endometriosis, even if  it can result in both false negative and 
false positive findings (83, 84). Laparoscopy along with histology, as a diagnostic tool, is 
believed to be both safe and successful, from the data currently available. Histological 
verification constitutes a good basis for further processing (85).  
There is wide variation in diagnosis and management of endometriosis worldwide which 
causes delayed diagnosis and suboptimal care.  Reports from Europe show an overall 
diagnostic delay of 4-10 years (30, 86, 87).  
 
2.1.5 Treatment 
 
Pharmaceutical treatment 
Endometriosis is a complex disease and the condition sometimes requires several areas of 
expertise for good therapeutic results with regard to pain. Medical treatment is often the first 
choice but can also be used in combination with surgical treatment when there is incomplete 
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removal of endometriosis lesions and also to prevent recurrence of the disease after surgery. 
Gestagens, Combined Oral Contraceptives (COC), and GnRH-agonists are the hormonal 
treatments for endometriosis used since the 1960’s (88-90). Analgesics are used 
simultaneously with hormonal treatment.  
Surgical treatment 
Surgery is usually performed due to drug-resistant pain, high suspicion of or previously 
verified endometriosis. The surgical trend for endometriosis is now more towards 
laparoscopic or minimal invasive surgery. In the 1970’s a diagnostic laparoscopy was more 
common and surgical procedures were mainly performed by laparotomy, but since the 1980’s 
more and more surgical procedures have been performed laparoscopically and even some as 
day surgery.  
 
2.1.6 Twin and family studies 
 
Increased concordance in monozygotic (MZ) twins (3) and familial accumulation of 
endometriosis (5, 8, 91) have been demonstrated in twin and family studies. Previous studies 
have reported a 3- 15 fold higher risk in first-degree relatives of women with endometriosis 
compared to controls from the general population (4, 7, 9, 92).  
Studies have been conducted to establish the heritability of endometriosis, i.e., the 
contribution of genetic factors. The largest twin-based study from Australia reported a two 
fold increase in endometriosis risk MZ compared to dizygotic (DZ) twin pairs and the genetic 
component contributing to the phenotypic variability of endometriosis was about 49-51% (3, 
93).  Details of related studies are presented in Table 1 and Table 2. 
 
Table 1 Twin studies in women with endometriosis 
 
Author Study design Number of 
twin pairs and 
singleton twins 
Number of 
cases or 
prevalence 
Genetic 
variance 
Treloar et al 
1999 
Cohort 
A questionnaire 
survey 
910 MZ pairs 
521 DZ pairs 
234 singleton 
Prevalence 
7,2% 
51% 
Nyholt et al 
2009 
Cohort 
A questionnaire 
survey 
815 MZ pairs 
457 DZ pairs 
 
 49% 
Hadfield et al 
1997 
Cohort  
A questionnaire 
survey 
16 MZ pairs 14 pairs 
concordant  
2 pairs 
discordant 
 
Moen et al 1994 Cohort 
A questionnaire 
survey with 
interview 
8 MZ pairs 75%  
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Table 2 Studies on familial aggregation of endometriosis 
 
Author Design Number of 
cases and 
controls 
Incidence Risk rating 
Stefansson et al 
2002 
Population-
based cohort, 
compared with 
matched 
controls 
750 cases  5 fold increased 
risk for sisters 
1,5 fold 
increased risk 
for first cousin 
Matalliotakis et 
al 2008 
Case control 485 cases 
197 controls 
9,5%  in first-
degree 
relatives 
1% in controls 
10 fold 
increased risk 
in first-degree 
relatives 
Kennedy et al 
1995 
Cohort 
A questionnaire 
survey 
230 cases in 
100 families 
with atleast 
two affected 
members 
 
19 mother-
daughter pairs, 
1 set of cousins 
and 56 sister 
pairs, 5 families 
with 3 affected 
sisters, 1 family 
with 5 affected 
sisters, 18 
families with > 
3 affected 
members 
Familial 
tendency  
Moen et al 
1993 
Case control 515 cases 
149 control 
Mothers: cases 
3,9%, control 
0,7%  
Sisters: cases 
4,8%, control 
0,6% 
7 fold increased 
risk in mothers 
and sisters 
Lamb et al 
1986 
Cohort 43 cases 34,9% of 
mothers, 21,2% 
of sisters were 
affected 
7 fold increased 
risk in first-
degree and 2 
fold increased 
risk for second-
degree 
relatives 
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2.1.7 Genetic determinants 
 
Endometriosis is recognized to have heritability and scientists are making great effort to 
search for specific susceptibility genes (number and location) for the occurrence of 
endometriosis. Two main approaches have been used: First, candidate gene studies which are 
“hypothesis-driven” and test one or more genetic variants which might be biologically 
relevant. The second approach is “hypothesis-free” with two variants. The first variant is 
GWAS, where scientists search the whole genome for rare and common genetic variants and 
the other variant is linkage mapping search for the disease causing variants in families.  
 
Candidate-gene studies in endometriosis  
 
Endometriosis may be caused by multiple genes as in other complex diseases. These studies 
are based on prior biological mechanisms considered to be responsible for the disease. They 
include cytokines/inflammation, steroid-synthesizing enzymes, hormone receptors, other 
enzymes and metabolic systems, growth factor system, adhesion molecules, matrix enzymes, 
apoptosis, cell-cycle regulation and oncogenes, human leukocyte antigen system and immune 
components. The search for genes started with “Candidate Gene Association” Studies 
(CGAS). Many candidate genes were investigated with small number of variants and with 
small number of cases and controls. An earlier review by Montgomery et al., (94) of seventy 
six studies until 1 April, 2008 reported no clear association of endometriosis with any gene 
variants.  Further, another review by Rahmioglu et al., (95) which included studies from April 
1 2008 to April 1 2012 concluded that no candidate gene was associated with endometriosis. 
Most of the single nucleotide polymorphism (SNP) studies failed to show any association 
with endometriosis due to factors like low statistical power and insufficient knowledge about 
both the biological mechanism of the disease as well as biological functions of the genes. A 
very large sample size is necessary to achieve convincing results. For example, a recent study 
which identified a common variant in Caspase-8 precursor (CASP8) associated with risk for 
breast cancer included 18, 000 cases and 22, 000 controls (96).   
 
Hypothesis-free genetic studies in endometriosis 
 
There are two approaches to examine the underlying genetic etiology. First is GWAS studies 
based on the hypothesis that common diseases are caused by genetic variants i.e. SNPs, 
which are common in the general population. Uno et al., (13) reported the first endometriosis 
GWAS in Japanese individuals and identified a significant association between endometriosis 
and the locus located in the cyclin-dependent kinase inhibitor 2B antisense RNA 
(CDKN2BAS) gene on chromosome 9. Painter et al., (11) who performed the first 
endometriosis GWAS on European ancestry identified a genome-wide significant intergenic 
locus on chromosome 7. Nyholt et al., (97) in a meta-analysis of the Japanese, Australian and 
UK GWAS data sets confirmed three previously identified loci and identified four new loci 
situated near Vezatin (VEZT), in an inter-genic region on chromosome 2, near the inhibitor of 
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DNA binding 4 (ID4) gene and near Cyclin-dependent kinase inhibitor B- antisense 
(CDKN2B-AS). A large two-staged GWAS included a replication sample of endometriosis 
including 2,019 cases and 14, 471 controls with only surgically-confirmed cases with >95% 
European ancestry could not replicate the immune evasion cluster (IEC) signal on 
chromosome 7 and two genome-wide significant signals near wingless-related MMTV 
integration site 4 (WNT4) and an inter-genic signal of Rho family guanosine triphosphate 3 
(GTPase 3) - RNA binding motif protein 43 (RND3-RBM43) (10).  A recent meta-analysis 
reported genome-wide association of SNPs in six loci with endometriosis among European 
and Japanese ancestry near WNT4, VEZT, CDKN2B-AS1, ID4 and in growth regulation by 
estrogen in breast cancer 1 (GREB1) (98). The result of a replication study in an Italian 
population confirms a locus near VEZT which was significantly associated with 
endometriosis and was the strongest among the SNPs identified by GWAS (99). The same 
study with more severe forms of the disease confirmed an association of SNPs in four out of 
five genetic loci with endometriosis (99). A very recent study further investigated eight 
interleukin 1-alpha (ILIA) SNPs using a sample of 3908 cases and 8568 controls of European 
and Japanese population and concluded that there was significant evidence of ILIA locus in 
endometriosis susceptibility which was stronger in moderate-to-severe endometriosis and 
also supports the suggestion for a link between inflammatory responses and the pathogenesis 
of endometriosis (100). The second approach is linkage mapping focused on genetic 
investigation of families with multiple affected individuals based on detecting disease-
causing variants in a family, but these variants are rare in the general population. Many 
families with multiple affected women are required to perform these studies. The 
international endogene study which investigated 1,176 affected sib-pairs from Australia and 
the United Kingdom identified a region of significant linkage on chromosome 10q26 (101). 
Another region was identified on chromosome 7q13-15 using a subset of 248 families with 3 
or more affected members. 
To summarize, genes have a strong influence on the development of endometriosis. Many 
genes or variants with small effects are suggested to have possible involvement. Previous 
studies on European and Japanese population have identified several loci, but the particular 
genetic variants causal to endometriosis are unknown so far. Further, to date, only a fraction 
of the heritability of endometriosis is explained. 
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Figure 1 Factors of importance in Endometriosis 
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2.1.8 Risk factors or markers of risk 
 
Besides heredity, few other established risk factors associated with endometriosis have been 
reported. Factors like early age at menarche, shorter menstrual cycle length, prolonged 
menstrual flow, nulliparity, increased age and increased peripheral body fat have been 
suggested as risk factors or markers of risk for endometriosis (1, 14-16, 18-21, 102, 103). An 
association between oral contraceptive pill (OC) and endometriosis is still unclear. Previous 
published studies have reported diverse association between OC and endometriosis (104-
106). Infertility has been estimated to affect up to 50% of women with endometriosis (2, 17). 
Whether infertility is causally associated with endometriosis or it is a consequence of 
endometriosis is not known so far. Endometriosis and infertility might have the same causal 
factor which needs to be investigated. Coffee consumption has been shown to increase the 
risk of endometriosis (22) and to have no association (107). Smoking has shown either a 
protective effect against endometriosis by decreasing estrogen levels (108, 109) or to have no 
association (110, 111). An increased risk for endometriosis with alcohol consumption was 
reported by a meta-analysis of 15 studies  (26), however, it was not possible to evaluate 
whether exposure preceeded the outcome.  
Previous quantitative genetic analyses have estimated that environmental factors also play a 
contributing role in risk of endometriosis, but evidence on the type of environmental 
contribution remains unknown. It is known that endometriosis is more common in urban than 
rural settings, most likely due to environmental contamination (112). Polychlorinated 
biphenyl (PCB) is an organic chlorine compound and is similar in structure and mode of toxic 
action as dioxin. Some studies suggest an association with certain PCBs and endometriosis 
(23, 27, 113), while other studies have failed to find a clear association (114, 115). It is 
proposed that the diet has a role in the development of endometriosis but very few studies 
have investigated this. One study conducted in Northern Italy, reported a significant reduction 
in the risk of endometriosis with high intake of green vegetables and fresh fruit. In contrast, 
an increased risk for endometriosis was associated with beef and other red meat and ham 
consumption (25). The environmental factors involved in the occurrence of endometriosis are 
still unclear.  
 
2.1.9 Studies on questionnaire 
 
Epidemiological and clinical studies are sometimes performed based on questionnaire 
including self-reported diagnosis. To estimate the accuracy and reliability of the self-reported 
diagnoses validity studies are necessary. To our knowledge, only few studies have been 
published to date on the agreement of self-reported diagnoses with a diagnosis in the in-
patient registries. Published studies on validity between self-reported diagnoses and medical 
records or hospital discharge diagnoses have shown diverse agreement (3, 28, 29, 103, 116-
119).  
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3 AIMS  
The overall objective of this thesis was to estimate the influence of heredity and the impact 
of reproductive and lifestyle factors on the occurrence of endometriosis and the validity of 
self-reported endometriosis and endometriosis-related questions among Swedish female 
twins. 
 
Specific aims 
 
- To estimate genetic and environmental influences on the occurrence of endometriosis and 
the prevalence of endometriosis among Swedish twins (Study I) 
 
-  To investigate the relations between reproductive and lifestyle factors with endometriosis 
in Swedish twins. (Study II) 
 
- To examine the validity of self-reported endometriosis and to improve the reliability of   
questionnaires by including endometriosis-related questions. (Study III) 
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4 SUBJECTS, STUDY DESIGN AND METHODS 
All three papers in this thesis are epidemiological studies, using large Swedish population-
based registers. Linkages between the registers were performed by the 10-digit Personal 
Identification Number (PIN) which is unique to each citizen living in Sweden. 
4.1 Population based register 
4.1.1 The Swedish Twin Registry (STR) 
The Swedish Twin registry (STR) is an extraordinary resource for the researcher. In the late 
1950s the registry was first established to study the association of lifestyle factors on cancer 
and cardiovascular diseases and also the genetic influences on the respective disease. So 
far, the STR is the largest twin registry in the world.  All twins born in Sweden since 1886 
are included. The registry comprises of more than 194 000 twins and more than 75 000 twin 
pairs (120). Between 1998-2002 one cross-sectional data, the Screening Across the 
Lifespan Twin (SALT) and during 2005-2006 another cross-sectional data, the Swedish 
Twin Study of Adults’ Genes and Environments (STAGE) collections has been undertaken. 
By using twin database hereditary and environmental factors can be investigated.  
 
SALT is a computer-assisted telephone interview based data collection performed during 
the period 1998-2002 and consists of twins born between 1886 and 1958, aged 40 years or 
older at the time of interview. Response rates were 65% for those twins born between 1886 
and 1925, and 74% for those twins born between 1926 and 1958 (121).   
 
STAGE is a web-based data collection performed during the period 2005-2006 and 
consists of twins born between 1959 and 1985, aged 20 to 40 years at the time of interview. 
Non-responders were interviewed over phone. The response rate was 59.6% (122).   
 
Zygosity determination 
Intra-pair similarities in childhood were considered in assigning zygosity. Twins were 
classified as monozygotic (MZ) if both the individuals of a pair replied “alike” and were 
classified as dizygotic (DZ) if both individuals of a pair replied “not alike”. They were 
classified as undetermined (XZ) if the twins replied differently, or if only one twin of the 
pair replied to the question. The zygosity classification was validated using 13 DNA 
markers with 98% or higher accuracy (120).  
Both the studies SALT and STAGE include the same set of questions. The entire 
questionnaire contained approximately 1300 questions, in 34 sections and included 161 
questions related to the woman’s health and 8 questions specific for endometriosis. 
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QUESTIONS USED FOR ALL THREE STUDIES OF THIS THESIS  
     
     Table 3 Endometriosis and endometriosis-related questionnaire   
      used by the Swedish twin registry 
1. Have you ever been diagnosed with endometriosis, also called chocolate cysts? 
 
2. How old are you at interview? 
 
3. What is the highest education you have undergone / are undergoing, how many 
years in total? 
 
4. Weight and height were reported at interview and the measures were used to 
calculate body mass index. 
 
5. How old were you when you had your first menstrual period? 
 
6. Number of children? 
 
7. Do you regularly use oral contraceptive pills as contraceptive? 
 
8. Do/did you experience severe menstrual pain? 
 
a. Do you take strong painkillers because of pain? 
b. Have you been absent from work due to pain? 
c. Do you take oral contraceptive pills because of menstrual pain? 
 
9. Do you experience pelvic pain in between menstrual periods? 
 
10. Do you experience painful intercourse? 
 
11. Have you been investigated or treated for infertility? 
12. How many cups of coffee do you drink on average per day (do not drink/ drink 
sometimes, 1-2 cups, 3-4 cups or 5 or more cups per day)? 
13.  Cigarette smoking and use of snuff were calculated according to an algorithm based 
on survey questions, whether they smoked or used snuff regularly, sometimes, or 
did not use? 
14.  Exposure of alcohol was assessed using a variable with weekly consumption of 
alcohol units (i.e., number of drinks per week) 
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4.1.2 The National Swedish In-patient Registry (IPR) 
The national Swedish in-patient registry (IPR) is preserved by the National Board of  
Health and Welfare and includes data on all hospital admission in Sweden. It started in1964 
and includes data for in-patient care in public hospitals. The registry covered 60% of  
in-patient care in 1969, 85% in 1983 and almost 100% coverage of in-patient care since 
1987. Visit to day surgery clinics and outpatient clinics were included since 1997 and 
2001 respectively. Data on the name of the hospital the patient was admitted, date of 
discharge, discharge diagnoses, surgical procedures performed are preserved and are 
available for the researcher. The discharge diagnoses in IPR are coded according to the 
International Classification of Diseases 8, 9 and 10 (ICD 8-10). 
The discharge diagnoses for endometriosis used in all three studies are for ICD 8 the codes 
are 625.30-625.33.625.38 and 625.39, for ICD 9, the codes  are 617A-617G and 617X, and 
for ICD10, the codes are N80.0-N80.9.  
 
4.1.3 Medical records 
Medical records are preserved at archives in respective hospitals and private outpatient 
clinic according to the Personal identification number (PIN). After receiving permission 
from the Regional Ethics Committee, and the patients’ consent, medical records 
could be retrieved.   
 
4.1.4 The Personal Identification Number (PIN) 
 
The National Tax Board maintains PIN since 1947, which is a ten-digit unique number for 
all citizens residing in Sweden since 1947. The entire Swedish health care system is 
covered by the Swedish PIN and linkages can be performed between different populations 
and medical registers (123). The ten digits represent in order, the year, month and day of 
birth followed by a four digit control number. For anonymity PIN were replaced by random 
index numbers by the authorities before delivery to the researchers. 
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4.2 An overview of the studies  
Table 4 An overview of all studies 
 Objective Study design Cases  Statistical 
analysis 
Study I To estimate the 
relative 
contribution of 
genetic and 
environmental 
influence on 
endometriosis, 
prevalence of 
endometriosis 
and validation 
of self-reported 
endometriosis 
with medical 
records 
Retrospective 
population-
based cross-
sectional cohort 
1,228 
Aged 20-65 
years 
 
3595 MZ and 
3601 DZ female 
twin pairs 
 
13,978 single 
female twins 
Descriptive 
statistics, t-test, 
Twin analysis, 
Chi-square test 
Study II To examine the 
relations 
between 
reproductive 
and lifestyle 
factors and 
endometriosis 
Retrospective 
population-
based cross-
sectional cohort 
1,228 
Aged 20-65 
years 
Descriptive 
statistics, 
Logistic 
regression, 
Conditional 
logistic 
regression 
Study III To investigate 
the validity of 
self-reported 
endometriosis 
and 
endometriosis-
related 
questions with 
data on 
endometriosis 
in IPR 
Retrospective 
population-
based cross-
sectional cohort 
1,168 
Aged 20-60 
years 
Descriptive 
statistics, 
Logistic 
regression, 
Receiver 
operating 
characteristics 
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4.3 Twin methodology 
 
The methodological background for twin studies is that MZ twins are genetically identical 
(share 100% of the genes), whereas DZ twins share about 50% of the genes (124). The 
higher proband-wise concordance and the within-pair correlations in MZ twin pairs 
compared to DZ twin pairs indicate genetic influence. By using twin methodology, a unique 
opportunity to examine the importance of hereditary factors for endometriosis is provided. 
Historically twin studies were described first in 1875.  Sir Francis Galton published an 
article entitled “The history of twins, as a criterion of the relative powers of nature and 
nurture” (125). The twin methodology has been widely used since then to perform 
quantitative estimation of genetic and environmental contributions on complex diseases.  
Structural equations relating to the observed disease can be written based on biometric 
genetic theory (126). In the classic twin model, the variance of an observed phenotype can 
be decomposed into three variance components: additive genetic factors (A), shared 
environmental factors (C), and non-shared environmental factors (E). Additive genetic 
effect is the total effect of the individual alleles at all loci which influence the disease. 
Shared environmental factors are non-genetic influences that make the twins similar, and 
non-shared environmental factors refer to non-genetic influences that make the twins 
different. Non-additive genetic effect is the interaction between alleles at the same locus 
(dominance, D) or on different loci (epistasis). The contribution of these latent factors can 
be estimated by comparing the similarity between MZ and DZ twins. Figure 2 illustrates the 
classic ACE model for analyzing twin data. 
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                       Figure 2 Classic ACE model for analyzing twin data 
 
The genetic correlation between twin pairs is 1 for MZ twins and 0.5 for same sex DZ 
twins. Under the equal environment assumption, the shared environment correlation is 1 for 
both MZ and DZ twins. The non-shared environment correlation is 0, by definition. 
If the ratio of twin pair correlations between MZ and DZ twin pair is 2:1 and almost no 
influence of shared environmental factors, then additive genetic influence is suggested 
(127). A ratio of more than 2:1 suggests the possibility of genetic nonadditivity. Possibility 
to detect nonadditivity in the classic twin study is low (128). Heritability is defined as the 
proportion of phenotypic variance among individuals attributable to genetic factors (124). It 
should be remembered that heritability does not refer to the genetic composition, rather, 
genetic contribution to the difference between individuals in a particular population.  
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4.4 Design and analysis in study I 
 
Study population  
 
A total of 38,154 female twins were retrieved from STR. Females over 65 years of age 
(n=9332) were excluded because they did not receive the question on endometriosis. 
Further, females with unknown zygosity (n=452) were also excluded. After exclusion, a 
total of 28,370 female twins were identified and out of them 1228 responded positively. 
Finally 3595 MZ and 3601 DZ female twin pairs, and 13,978 single female twins were 
included in the twin analysis.  
 
Validation of self-reported endometriosis data 
 
We sent letter to all women with self-reported endometriosis and were still alive for their 
consent to retrieve their medical records. Of the 1228 women 18 were not alive and of the 
1210 women 737 gave consent. To obtain a medical record, we then sent a letter to all 
hospitals and private clinics. Of the total 737, we received 442 medical records from 44 
hospitals and 5 private gynecological outpatient clinics. Information on diagnosis of 
endometriosis by surgery, histology or also clinically (medical history, clinical examination 
and sonography) were scrutinized and recorded in a structured protocol.  
 
Statistical methods 
 
Summary statistics was used to estimate mean and + standard deviation of age. 
Proband-wise concordance was estimated by using 2×2 contingency tables for MZ and DZ 
twin pairs Correlation of liability (tetrachoric or within-pair correlation) was also estimated 
for each zygosity group. To estimate the heritability of endometriosis, quantitative genetic 
models were used under the assumptions of the classical twin designs. Akaike Information 
Criterion (AIC) was used to determine the best-fitting model. 
Statistical analysis was conducted using STATA IC 12 (StataCorp 2011. Stata Statistical 
Software: Release 12, College Station. Tx: StataCorp LP) and the package OpenMx, 
version 1.4–3060, in the statistical software R, version 3.1.1 (R Foundation for Statistical 
Computing, Vienna, Austria).   
 
4.5 Design and analysis in study II 
 
Study population   
 
The cohort consisted of total 28,822 female twins including 3,595 MZ and 3,601 DZ female 
twin pairs aged 20-65 years at interview. Among 28,822, 1,228 reported positively to the 
question about endometriosis diagnosis, which was validated with medical records.  
 
 
 
  21 
Exposure variables 
 
Potential risk factors or markers of risk considered were age at menarche, level of 
education, body mass index (BMI, kg/m
2
), parity, OC, infertility, coffee consumption, 
cigarette smoking, snuff, alcohol consumption. Risk factors or markers of risk were 
assessed by questionnaire extracted from the STR.  
  
Statistical methods 
 
Descriptive statistical analysis was used to estimate the characteristics of subjects including 
response rate of potential risk factors or markers of risk for subjects with and without 
endometriosis. Further, logistic regression analyses with cluster robust standard errors were 
performed to calculate the odds ratios (OR) with 95% confidence intervals (CI). 
Conditional logistic regression analyses for co-twin control were performed for the 
statistically significant risk factors or markers of risk and were considered as a sensitivity 
test. 
Statistical analysis was conducted using STATA IC 12 (StataCorp 2011. Stata Statistical 
Software: Release 12, College Station. Tx: StataCorp LP) 
 
4.6 Design and analysis in study III 
 
Study population  
 
A total of 28, 822 female twins aged 20-65 years at the time of interview replied the 
question on endometriosis in STR. We excluded women who were older than 60 years of 
age, because IPR covered almost 100% since 1987. After exclusion, the final figure for 
total population was 26, 898 and 1168 replied positively to the question on endometriosis. 
We linked STR with IPR to identify cases who received endometriosis diagnoses during 
discharge from the hospital. We identified 602 cases of endometriosis from IPR. 
Statistical methods 
 
First, we calculated the descriptive information of self-reported endometriosis and 
endometriosis-related questions. Secondly, we calculated the measures of agreement like 
sensitivity, specificity and area under the curve (AUC) between self-reported data and data 
on endometriosis in IPR.  
To determine the variables which were independently associated with overall agreement, 
logistic regression analysis was performed. Further, sensitivity and specificity of self-
reported endometriosis, age and infertility were plotted on a receiver operating 
characteristics (ROC) curve to determine the prediction of endometriosis diagnosis in IPR. 
Statistical analysis was conducted using STATA IC 12 (StataCorp 2011. Stata Statistical 
Software: Release 12, College Station. Tx: StataCorp LP) 
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4.8 ETHICAL REFLECTION 
Swedish law permits research on human subjects only if the potential scientific value of the 
research project in question far exceeds the risks that the study participants could be 
exposed to (Swedish Riksdag lag 2003:460). In contrast to experimental and interventional 
studies, observational studies in general have a lower risk of inflicting harm on participants 
involved. In the current thesis, all data has been extracted from the STR, for which prior 
ethical approval was obtained.  Ethical approval for SALT and STAGE in STR have 
number FEK KI Diary number 94-280, FEK KI Diary number 00-132 and FEK CI 03-224 
respectively. All studies were reviewed and approved by the Regional Ethics Committee in 
Stockholm, Sweden (diary number 2009/1676-31/2).  
All potential participants received written information about the study.  Written informed 
consent was taken from those women who wished to participate, before their medical 
records were retrieved. This indicates the voluntary nature of the study.  
All personal information was kept strictly confidential. Data accounts were anonymous at 
the group level and no individual data has been presented. No patient identifier information 
was used in the statistical analysis either. All patient files were kept locked and only study 
personnel had access to them. Database access was limited to the study biostatistician and 
myself.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  23 
5 RESULTS 
 
5.1 Study I - Heritability of Endometriosis 
 
We received a total of 442 medical records. Out of these, we could confirm the self-
reported endometriosis diagnosis in 360 cases (360/442=82%), which was considered to 
have acceptable validity. Of 360 validated cases 287 were diagnosed surgically 
(287/360=80%) and 73 (73/360=20%) clinically. The prevalence was estimated to be 4.3% 
(95% CI: 4.1, 4.6) and there was no significant difference in prevalence between MZ 
compared with DZ twins (p-value =0.23). 
The proband-wise concordance and the within-pair correlations were estimated to be higher 
in MZ twin pairs (0.21, 0.47) than in DZ twin pairs (0.10, 0.20), which indicates that there 
is genetic influence. We found the AE model allowing for additive genetic and 
environmental effects to be the best model. The heritability of endometriosis was 47% and 
the unique environmental effect was 53% (Table 5).  
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Table 5 Parameter estimates and model fit statistics of genetic and 
environmental effects on endometriosis among Swedish female twins 
Model     Parameter estimates (95% CI
a
)                    Fit of model 
 A C E LLb  dfc p-valued AICe 
SATf    9942.94 6  -46785.06 
ACEg 47% 
(20%,57%) 
0%  
(0%,22%) 
53% 
(43%,64%) 
9947.02 3 0.25 -46786.98 
AEh 47% 
(36%,57%) 
 53% 
(43%,64%) 
9947.02 2 0.39 -46788.98 
CE  35% 
(26%,43%) 
65% 
(57%,74%) 
9956.90 2 0.01 -46779.10 
E   100% 10014.49 1 0.00 -46723.51 
a
95% CI: 95% profile likelihood confidence interval 
b
LL: -2 log likelihood  
c
df: Degrees of freedom  
d
p-value: Significance of difference in -2 log likelihood compared to the saturated model 
e
AIC: Akaike information criterion 
f
SAT: Saturated model 
g
ACE: Additive genetic (A), shared environment (C), unique environment (E)   
h
AE: Was the best–fitting and most parsimonious model according to AIC 
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5.2 Study II - Reproductive and lifestyle factors associated with endometriosis in a 
large cross-sectional population sample 
 
The response rate to the questionnaire was very high except for the question about snuff, 
where the non-response was 63%. We found that late age at menarche was associated with 
a decreased risk for endometriosis with an OR of 0.75 at 14 years and an OR of 0.63 at 15 
years and parity of two or more children had an inverse association with endometriosis (OR 
0.70). There was a significant association between infertility and endometriosis with an OR 
of 5.04. We found no evidence of association between regular use of OC, BMI, daily 
consumption of coffee and smoking with endometriosis (Table 6).  
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Table 6 Odds ratios for probable risk factors or markers of risk for     
endometriosis  
Potential risk factors OR (95% CI) 
 
OR
a
 (95% CI) 
 
Age at menarche, year 
<11 
12 
13 
14 
15, or more 
 
Ref 
0.79 (0.65,0.97) 
0.81 (0.67,0.98) 
0.72 (0.59,0.88) 
0.63 (0.51,0.79) 
 
Ref 
0.82 (0.66,1.01) 
0.83 (0.67,1.01) 
0.75 (0.60,0.93) 
0.63 (0.50,0.81) 
Body mass index (kg/m
2
) 
<18.5 
18.5-24.9 
25-29.9 
30 or more 
 
0.78 (0.52,1.17) 
Ref 
1.20 (1.05,1.37) 
1.15 (0.92,1.44) 
 
1.30 (0.82,2.22) 
Ref 
1.49 (0.93,2.37) 
1.36 (0.82,2.26) 
Parity 
0 
1 
2 or more 
 
Ref 
1.38 (1.15,1.64) 
0.99 (0.86,1,15) 
 
Ref 
0.86 (0.70,1.05) 
0.70 (0.59,0.83) 
OC as contraceptive 
Nonuser 
Regular user 
 
Ref 
0.81 (0.70,0.95) 
 
Ref 
0.88 (0.74,1.04) 
Infertility 
No 
Yes 
 
Ref 
6.34 (5.56,7.23) 
 
Ref 
5.04 (4.35,5.83) 
 
Coffee/day 
sometime 
1-2 cups 
3-4 cups 
5 cups or more 
 
Ref 
1.20 (1.01,1.41) 
1.28 (1.09,1.51) 
1.47 (1.21,1.79) 
 
Ref 
1.10 (0.91,1.32) 
1.04 (0.88,1.24) 
1.09 (0.88,1.39) 
Smoking 
Nonsmoker/sometime 
Regular smoker 
 
Ref 
1.29 (1.15,1.46) 
 
Ref 
1.11 (0.97,1.27) 
Alcohol intake (drinks/week), unit  
Non-user 
>0-<4.5 
>4.5-9 
>9 or more 
 
Ref 
0.90 (0.76,1.07) 
0.71 (0.57,0.89) 
0.76 (0.56,1.03) 
 
Ref 
0.94 (0.78,1.13) 
0.88 (0.70,1.12) 
0.91 (0.65,1.28) 
OR: Odds ratio, CI: Confidence interval, OC: Oral contraceptive pill 
a
Adjusted for age at interview (20-65years), age at menarche, body mass index, parity, OC 
as contraceptive, infertility, coffee, smoking and alcohol intake 
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Within-pair analyses as sensitivity analyses confirmed the inverse association between 
parity of two or more children (OR 0.31) and endometriosis and the association between 
infertility (OR 2.65) and endometriosis.  
5.3 Study III – Validity of self-reported endometriosis and endometriosis-related 
questions in a Swedish female twin cohort  
The response rate was 100% for self-reported endometriosis, age at interview, infertility 
and OC pill. On the contrary, the non-response rates were about 30% for severe 
dysmenorrhea, pelvic pain and dyspareunia (Table 7). 
We found high specificity for all variables except for severe dysmenorrhea while sensitivity 
was low (Table 8). 
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Table 7 Response of self-reported endometriosis and endometriosis-related 
questions in STR
a
 with endometriosis diagnosis in IPR
b
 among women aged 
20-60 years  
Questionnaire in STRa Endometriosis in IPRb 
n (%) 
No endometriosis in 
IPRb n (%) 
Missing values 
n (%) 
Age at interview, year 
20-30 
31-40 
41-50 
51-60 
 
8 (1.33) 
52 (8.6) 
213 (35.4) 
329 (54.65) 
 
4 835 (18.4) 
4 826 (18.4) 
7 962 (30.28) 
8 673 (33.0) 
 
0 
0 
0 
0 
Self-reported 
endometriosis 
Yes 
No 
 
372/602 (61.8%) 
230/602 (38.2) 
 
796/26 296 (3.0) 
25 500/26 296 (97.0) 
 
0 
0 
Severe dysmenorroea 
Yes 
No 
 
123/602 (20.4) 
91/602 (15.1) 
 
5680/26 296 (21.6) 
12 990/26 296 (49.4) 
 
8014 (30.5%) 
Chronic pelvic pain 
Yes 
No 
 
53/602 (8.8) 
161/602 (26.7) 
 
2029/26 296 (7.7) 
16 641/26 296 (63.3) 
8014 (30.5%) 
Dyspareunia 
Yes 
No 
 
34/602 (5.7) 
180/602 (3.0) 
 
752/26 296 (2.9) 
17 918/26 296 (68.1) 
 
8014 (30.5%) 
Infertility 
Yes 
No 
 
167/602 (27.7) 
435/602 (72.3) 
 
 
1900/26 296 (7.2) 
24 392/26 296 (92.8) 
 
0 
0 
Oralpill as contraceptive 
Yes 
No 
 
99/602 (16.5) 
503/602 (83.6) 
 
5297/26 296 (20.1) 
20 999/26 296 (79.9) 
 
0 
0 
a
STR: Swedish Twin Registry,
  b
IPR: Swedish National Inpatient Registry 
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Table 8 Measures of agreement between self-reported and national register 
data on endometriosis in a Swedish twin cohort
 
Questions in 
STRa 
Sensitivity Specificity ROCb area 
Self-reported 
endometriosis  
61.8% 97.0% 0.79 
Severe 
dysmenorrhea 
57.5% 69.6% 0.64 
Chronic pelvic 
pain 
24.8% 89.1% 0.57 
Dyspareunia 15.9% 96.0% 0.56 
Infertility 27.7% 92.8% 0.60 
Oral pill as 
contraceptive 
16.4% 79.9% 0.48 
a
STR: Swedish Twin Registry, 
b
ROC: Receiver operating characteristics 
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Our result showed that the prevalence of endometriosis increases with age until 40 years in 
self-reported data and until 50 years in IPR.  
Predictive ability of self-reported endometriosis having a confirmed endometriosis 
diagnosis in IPR was good with an AUC of 0.79. Additional information about age and 
infertility increases the predictive ability to AUC of 0.89 (Figure 3).  
 
 
                   Figure 3 Receiver operating characteristics for prediction of  
                      Endometriosis diagnosis in the in-patient registry 
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6 DISCUSSION 
6.1 Interpretation of findings and implications 
Despite the high prevalence of endometriosis, there is limited knowledge of its etiology as 
well as risk factors or markers of risk. This thesis aimed to acquire more knowledge about 
the influence of genetic and other factors of importance for example, age at menarche, 
parity, OC, coffee consumption, smoking and alcohol consumption on the occurrence of 
endometriosis.  
 
6.1.1 Study I - Genes have a strong influence on endometriosis  
 
Findings 
 
In paper I, we found that an additive genetic effect contributes about 50% to endometriosis 
etiology, while the remainder was explained by unique environmental factors. Further, we 
confirmed self-reported endometriosis with medical records in 82% cases and the 
prevalence of endometriosis was estimated to be 4.3%.  
 
Interpretation 
 
Diversity in diagnostic methods and delay in diagnosis makes it difficult to estimate the 
true prevalence. The prevalence estimate in our study is slightly higher than previous 
reports from non-twin samples in the USA (2.5–3.3%) and the UK (1.8%) (129-131), but 
lower than reports from the Australian twin sample (7.2%) (3). The explanation might be 
differences in selection criteria and sample size. The interpretation of the results on 
prevalence depends on the representativeness of the twin population compared with the 
Swedish female population. Studies have suggested that the results of twin studies can be 
generalized to singleton populations (132-134). The validity of self-reported endometriosis 
diagnosis in this study was acceptable.  
The genetic contribution of 47% to the occurrence of endometriosis is consistent with a 
study performed on an Australian twin sample (3). Increased concordance in MZ twins (3), 
familial accumulation of endometriosis (5, 6, 8) and 3-15 fold higher risk in first-degree 
relatives of women with endometriosis (4, 7, 9, 92) have been demonstrated. All these 
above mentioned studies suggest the genetic influence on endometriosis. Thus, our results 
using a large population-based twin sample strengthen the previous hypothesis that genes 
have a strong influence on endometriosis. The remainder 53% was explained by the unique 
environmental factors, suggesting that they also have an important role in endometriosis. It 
is reported that endometriosis is more common in urban than rural settings (112). While 
some studies have reported association between certain dioxins, PCBs and endometriosis 
(23, 27, 113), other studies did not find any association (114, 115). One study reported a 
significantly decreased risk of endometriosis with intake of green vegetables and fresh 
fruits and increased risk with beef and ham consumption (25). Thus, diet also has a role in 
endometriosis. Although few studies suggest about the role of some environmental factors 
on endometriosis, the evidence on the types of environmental factors is unknown.  
The strengths of this study are the large population-based sample and the validation of self-
reported endometriosis diagnosis by medical records.  
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One weakness was that in STAGE, young women (20-40 years) were included and all 
women had not received their endometriosis diagnosis yet, which might have contributed to 
underestimation of the prevalence. Another weakness was that there were women who had 
no symptoms and were diagnosed only by histology by chance. Hence they were not aware 
of their diagnosis and did not report positively which could also have underestimated the 
prevalence. Further, not all women received their diagnosis even if they had symptoms, as 
many did not seek medical help, assuming that dysmenorrhea is a normal condition. 
Unfortunately, 18% of medical records did not support endometriosis or had information 
only on adenomyosis without endometriosis. One probability could be that adenomyosis 
and endometriosis were previously considered as a single entity. The other probability 
could be that we did not receive the right medical record for those women.  
 
Implications  
 
Our result strengthens the hypothesis that genes have a strong influence on the development 
of endometriosis. There is only one similar study published previously, by Treloar et al., (3) 
in 1999 based on the Australian twin cohort, involving a much smaller group of women 
(3,300 women, 215 self-reported endometriosis cases). Therefore this study represents an 
important contribution to the body of evidence for a genetic basis of endometriosis. 
 
6.1.2 Study II – Reproductive and lifestyle factors associated with endometriosis 
 
Findings 
 
The results showed inverse associations between reproductive factors like late age at 
menarche and higher parity, with endometriosis. On the contrary, infertility was strongly 
associated while OC showed no statistically significant association with endometriosis. For 
BMI, coffee consumption, smoking and alcohol consumption, no statistically significant 
associations were observed. 
 
Interpretation 
 
An inverse association between late age at menarche and endometriosis was found in the 
current study which is consistent with other studies (18, 20). It is described that women 
with early menarche have higher levels of serum and urine estradiol concentrations (135, 
136) and higher level of urine estrone concentrations (136) during the follicular phase of 
the menstrual cycle. High levels of estradiol might have an influence on endometriosis 
(137-139) as estrogen has influence on growth, differentiation and function of eutopic 
endometrium which might explain why early menarche is associated with endometriosis 
(17, 140-143).  One probable weakness could be uncertainty of the self-reported age at 
menarche but it would have also influenced the patients without endometriosis.  
About the inverse association of parity with endometriosis, our speculation is that women 
with endometriosis are less fertile and hence less prone to have two or more children. This 
result is in line with the previous studies (17, 19, 21, 144, 145). Strong association between 
infertility and endometriosis have been described previously (145, 146), but the knowledge 
about the causality is unclear. Our result did not show any statistically significant 
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association between OC and endometriosis in the adjusted analysis, which is consistent 
with some previous studies (15, 105). Previous studies have also reported a protective effect 
(106, 147) and an association with endometriosis (148, 149). Different results might be due 
to varying indications and duration of treatment in individuals. The strength of our study is 
that we only considered women using OC solely as contraceptive purpose. 
Our result on BMI showed no association with endometriosis which is not in line with other 
studies since, they have shown either positive or inverse associations (14, 24, 103, 150, 
151).  The weakness of our study is that women were asked about their BMI at interview 
and most probably they had a higher BMI then than when they were younger, because BMI 
increases with age (152). There was no statistically significant association between coffee 
consumption and endometriosis. A similar result was reported in a previous meta-analysis 
(107). We did not find any association between smoking and endometriosis, which is 
consistent with a previous large meta-analysis (110). There was no association between 
alcohol consumption and endometriosis. One previous meta-analysis showed an increased 
risk for endometriosis with alcohol consumption (26) but there was a limitation in 
evaluation as to whether exposure occurred before or after the development of 
endometriosis. 
The strength of this study is the large population-based sample.  
One weakness is the possibility of reverse causality because it is a cross-sectional study, 
exposure and outcome was ascertained at the same time point hence we do not know 
whether exposure preceeded the development of the disease. One limitation for all 
endometriosis studies is that it is unknown whether asymptomatic women are free from the 
disease. One drawback could be the different ways of interpretation of a question by the 
respondents. Further, recall bias is also a problem with questionnaires if the respondents 
have to reply to some questions like symptoms and signs, lifestyle factors and other 
personal questions a long time after they had their experience. 
 
Implications 
 
The results from our study about a protective effect of late age at menarche on 
endometriosis and a strong association between infertility and endometriosis in a large 
population-based sample strengthen the previous knowledge and findings. Our results on 
OC showed neither a protective effect nor higher risk for the occurrence of endometriosis. 
Thus, we can neither oppose or support the use of OC for primary prvention of 
endometriosis.  
  
6.1.3 Study III – Self-reported endometriosis is moderately acceptable 
 
Findings 
 
The predictive ability of self-reported endometriosis having an endometriosis diagnosis in 
IPR was good and was even better when additional information about age and infertility 
was added. Further, our results showed a high specificity for self-reported endometriosis 
and endometriosis-related questions and prevalence of endometriosis increased with age.  
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Interpretation 
 
Endometriosis is a common gynecological disease. Good national registers are needed to 
perform clinical and epidemiological research. To our knowledge, this is the first study on 
the validity and reliability of self-reported endometriosis and endometriosis-related 
questions with data on endometriosis in IPR. On the contrary, previous studies have 
validated self-reported data on endometriosis with medical records with good agreement (3, 
153). Our results showed good agreement between self-reported endometriosis in STR and 
endometriosis diagnosis in IPR and the predictive ability of self-reported endometriosis 
having an endometriosis diagnosis in IPR increased when there was additional information 
about age and infertility.  
We investigated the frequency of endometriosis among those who responded positively to 
the questions on symptoms for example, severe dysmenorrhea, pelvic pain, and 
dyspareunia. In a previous study, prevalence of dysmenorrhea and dyspareunia were 62% 
and 55% respectively in women with endometriosis (68). However, we investigated the 
frequency of endometriosis in IPR among those who replied positively to the questions on 
severe dysmenorrhea and dyspareunia symptom in STR and the results were 20% and 6% 
respectively. To our knowledge, there is no such study published to date to compare our 
results on prevalence of endometriosis with history of severe dysmenorrhea and 
dyspareunia. We found a frequency of 9% endometriosis in IPR among those who 
responded positively to the question on pelvic pain symptom which is much lower 
compared to a review including only very small sample sized studies (154). The present 
study reported that 28% of infertile women received an endometriosis diagnosis in IPR, 
which is in line with the previous studies (2, 17).  
Implications 
This study concluded that the self-reported data may be useful in clinical and 
epidemiological studies, similar to what is described in other studies performed on other 
diseases (28, 29, 117, 118). 
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6.2 Methodological considerations 
6.2.1 Study design 
 
Cohort studies consist generally of a group of individuals who are followed over time and 
then the outcome, the occurrence of the disease is recorded. Prospective cohort studies are 
followed forward in time and then the outcome is recorded, while in retrospective cohort 
outcome has already occurred and the data on exposure and outcome is retrieved from the 
registers.  
Paper I-III are retrospective cohort studies. Individuals were identified from the STR. Data 
from STR were linked with data from IPR. In STR the exposure and outcome were 
collected at the same time point, at interview.  
 
6.2.2 Internal validity 
  
Random and systemic errors are the two major types of errors considered in 
epidemiological studies. Systemic error is also called bias and is divided into selection bias, 
information bias and confounding. Random errors are the variability in the data and can be 
decreased with increased sample size.  
 
6.2.2.1 Selection bias 
 
Selection bias refers to a selection of subjects included in the study. A selection bias might 
have been introduced if the association between exposure and outcome differs between 
participants and non-participants. Case-control studies are more prone to selection bias than 
cohort studies since selection bias can be minimized by collecting data prospectively.  
 
Response rates in SALT were 65% and 74% for those twins born between 1886 and 1925 
and 1926 and 1958 respectively. In STAGE the response rate was 59.6% for those twins 
born between 1959 and 1985. A selection bias could have been introduced if for instance 
more responders came from university hospitals and non-responders from county hospitals 
because there is variability in diagnosis, treatment regimens and resources between the two. 
 
6.2.2.2 Information bias 
 
An information bias error occurs when a variable is measured wrongly and places the 
subject in the wrong category and one should consider that misclassification has occurred. 
Misclassification can occur for both exposure and outcome and it can be differential or non-
differential. A misclassification of exposure is differential if it is different for those with 
and without the outcome and non-differential if it is unrelated to the outcome. The same is 
true regarding misclassification of the outcome. Differential misclassification can either 
overestimate or underestimate an effect. Non-differential misclassification estimates the 
effect which is closer to a no-effect value than the actual effect.  
In all three studies information on self-reported endometriosis diagnosis was retrieved from 
STR and we were not able to distinguish endometriosis from adenomyosis, which allows 
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for overestimation of the prevalence estimate for endometriosis. Here it is inevitable to 
introduce a misclassification.  
In study II we had several exposure variables and the true exposure time might be unclear 
and it is inevitable to introduce misclassification. However, it will be a non-differential 
misclassification, since the differences between cases and controls are not likely in this 
respect. 
 
6.2.2.3 Confounding 
 
Confounding is a problematic factor that is associated with both exposure and outcome but 
is not an effect of the exposure (Figure 4). The effect of one exposure is mixed with the 
effect of another exposure which leads to bias. It can cause either an overestimation or an 
underestimation of the effect. Prevention of confounding can be done by randomization and 
restriction. With randomization one can control unknown confounders, however, not with 
restriction. Further, by stratifying the data where the confounder is held constant within 
each stratum, prevention can be done for confounding. Furthermore, by matching 
distributions of factors between the cases and controls, prevention of known confounders 
can be achieved, which can be performed in both cohort and case-control studies. In 
regression analyses several probable (and measured) confounders can be included 
simultaneously and adjusted for.  
In study II where we investigated the association between different risk factors or markers 
of risk for endometriosis, we controlled for age and zygosity, and also adjusted all the 
potential risk factors in the statistical analyses to avoid known confounding.  
 
 
 
                
                             Exposure                  Outcome 
 
 
 
                                                     Confounder 
 
Figure 4 Theoretical model of a confounder acting on both exposure and outcome 
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6.2.3 Twin methodological issues 
 
6.2.3.1 Equal environment assumption 
 
Equal environment is one of the fundamental assumptions in twin methodology. It is 
assumed that the similarity caused by environment is mostly the same for both MZ and DZ 
twins reared in the same family. The assumption is violated if MZ twins are treated more 
similarly than DZ twins and the genetic effect will be inflated. Studies have indicated that 
the assumption is valid for attention deficit hyperactivity disorder (ADHD) and other 
psychiatric disorders (155, 156).   
 
6.2.3.2 Additive genetic effect 
 
The basic twin model often focuses on additive genetic effects, assuming that the effects of 
alleles at a locus and across loci are independent and, therefore, additive (124). 
 
6.2.3.3 Non-additive genetic effect 
 
The effect of alleles can interact with other alleles at the same locus (dominance) or at other 
loci (epistasis) (124). Non-additive genetic effects may be present if MZ correlations are 
more than half of DZ correlations.  
 
6.2.3.4 Gene-environment interaction/correlation 
 
The basic assumption of twin model is that the influence of genes and environment on a 
phenotype is independent. Genes and environment have direct effect. Further, there may be 
an interplay between genes and environment through gene-environment interactions and 
correlations (157). Individuals of the same genotype may respond differently to 
environments due to gene-environment interactions. The epigenetic disruption of gene 
expression plays an important role in the development of endometriosis through interaction 
with environmental changes (158). Individuals with different genotypes are selectively 
exposed to different environments due to gene-environment correlation. 
In study I quantitative genetic modelling was performed under the assumption of classic 
twin design which is random mating that result in no gene-environment interaction due to 
equal environments in MZ and DZ twin pairs (126). 
 
6.2.3.5 Generalizability from twins to singletons 
 
Twins may differ from singletons regarding lifestyle characteristics and psychological 
development (159). In one study from UK compared certain diseases and prevalence of 
lifestyle characteristics between twins in the St Thomas’ Hospital UK adult twin registry 
consists of 600 MZ and 1,400 DZ female twin pairs and population-based singleton 1,003 
women aged between 45 to 65 years reported that there were few or no differences 
regarding prevalence or variances for height, bone mineral density in the hip, osteoarthritis 
in the knee and hip, systolic blood pressure, anti-hypertensive pharmaceutical treatment,  
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menopausal status, history of hysterectomy and oophorectomy, and for overall tobacco and 
current alcohol consumption (132). Another study from Finland comparing twins with 
singletons consisting of 122 twins and 5455 singletons in the National Epidemiological 
Child Psychiatric study, reported no significant difference in the mean scores for 
hyperactivity (134). An Australian study reported that female twins are representative of the 
Australian population regarding age, general level of education, and marital status (133). 
Several studies have suggested that the results of twin studies can be generalized to 
singleton populations (132-134), but the interpretation of results of twin studies should be 
made carefully with special consideration to the nature of the sample.   
 
6.2.4 Generalizability 
 
All three studies in this thesis used data from Swedish female twin population. The 
magnitude of heritability of endometriosis and the associations of other variables with 
endometriosis were mostly similar to other previous studies. Anyhow, our findings are not 
exactly the same as other countries and thus, generalizations from the results of these 
studies should be made with caution.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  39 
7 CONCLUSIONS  
 
 Our results suggest that both genetic and environmental factors have influence on 
the complex etiology of endometriosis. The prevalence of endometriosis was 
estimated to be 4.3%. Self-reported endometriosis could be validated with medical 
records in 82% of cases. 
 
 Infertility was found to be strongly associated with endometriosis but the 
knowledge about the causality is unclear. This finding motivates further research on 
causality and whether they have a common genetic origin. 
 
 Inverse association between late age at menarche and endometriosis was observed 
and may be considered as having a protective effect on endometriosis. Parity with 
two or more children was inversely associated with endometriosis and we speculate 
that women who have endometriosis are less fertile and are thus less prone to have 
two or more children. These findings highlight the need to increase awareness in 
clinical practice. 
 
 Use of oral contraceptives (OC) solely for contraceptive purpose did not show any 
significant association with endometriosis. Based on the results of this study, we can 
neither oppose or support the use of OC for primary prvention of endometriosis.  
 
 Good predictive ability of self-reported endometriosis having a confirmed 
endometriosis diagnosis in the IPR was found in our study. The predictive ability 
increases with additional information on age and infertility.Thus, self-reported data 
on endometriosis may be useful for clinical and epidemiological studies when 
register data are not available. 
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8 FUTURE PERSPECTIVES 
 
8.1 Can we find genes that cause endometriosis? 
 
It has been suggested that genes have a strong influence on the development of 
endometriosis. Previous studies on European and Japanese populations have identified 
several loci, but the definite genetic variants causal to endometriosis are not yet defined. It 
has been suggested that several gene variants with small effects are likely to be involved in 
the etiology of endometriosis. Studies have suggested a role for gene-gene and gene-
environment interactions in the occurrence of endometriosis (160, 161), but the results are 
in a very preliminary stage. To assess gene-gene and gene-environment interactions 
robustly without a strong prior hypothesis, well-designed studies in even larger samples 
than used for GWAS studies are necessary. Endometriosis research groups worldwide need 
to acquire similar strategies and work collectively to combine data to identify genes 
contributing to the disease. Future studies should also focus on including cases with 
detailed endometriosis subtypes. Successful evidence for genes associated with 
endometriosis may open up the possibility for functional and biological studies which may 
further develop better diagnosis and treatment for this debilitating disease. Further, research 
in animal models for example the rhesus and the baboon might add knowledge about the 
genetics of endometriosis.  
 
 
8.2 Do endometriosis and infertility share a common cause? 
 
Studies have shown up to 50% association of infertility with endometriosis and the vice 
versa. We do not know so far, whether they are sharing a common cause or which one of 
them causes the other. They may share a common genetic effect and further studies need to 
investigate this issue.  
 
 
8.3 Can we improve the accuracy of self-reported endometriosis diagnosis? 
By including highly structured detailed questionnaires focusing on symptoms, signs, 
subtypes of endometriosis, we may probably improve the accuracy of self-reported 
endometriosis.  
 
8.4 How can we perform good epidemiological studies on endometriosis?  
Previous epidemiological studies have mostly been performed with small sample sizes. 
They have also been poorly-designed and mostly with retrospective nature. To minimize 
the limitations we should in the future focus on well-designed prospective studies with 
more information about confounders. Future studies should also focus on other potential 
risk factors or markers of risk for endometriosis which were not previously studied for 
example environmental factors or exposure to drugs. The possibility of linkages between 
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drug registers and in-patient register should be considered for future studies on exposure to 
drugs. 
The Swedish national registers are gold mines for performing epidemiological studies. We 
need to establish a national register for endometriosis with hospital discharge diagnoses, 
diagnoses from day surgery department, clinical diagnoses in the outpatient department and 
highly structured self-reported questionnaire which women should respond to before 
clinical and surgical diagnosis and treatment.  
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9 SAMMANFATTNING PÅ SVENSKA 
Endometrios är en kronisk inflammatorisk östrogenberoende sjukdom som drabbar cirka 10% 
av alla fertila kvinnor. Menstruationssmärta är det vanligaste symptomet men kronisk smärta 
i buken och bäckenet, smärta vid samliv och infertilitet är också associerade med 
endometrios. Det är känt att både genetiska och miljömässiga faktorer bidrar till utvecklingen 
av sjukdomen, men mekanismerna för deras samexistens i sjukdomsprocessen är inte helt 
kända. Det är mycket lite känt om ärftlighet för endometrios hittills. Tillståndet antas vara 
orsakad av multipla gener och så kallade Genom-wide associationsstudier har påvisat vissa 
loci som förknippats med endometrios men specifika genetiska varianter har inte beskrivits 
ännu. Vilka typer av miljöfaktorer som är involverade, har ännu inte kunnat visats. Tidigare 
studier har föreslagit samband mellan olika livsstilsfaktorer och reproduktiva faktorer men 
betydelsen av dessa faktorer är inte klarlagd.  
Denna avhandling syftar till att dels uppskatta förekomsten av endometrios och ärftlighetens 
betydelse (Studie I), dels effekterna av reproduktiva och livsstilsfaktorer på förekomsten av 
endometrios (Studie II) och slutligen överensstämmelsen av självrapporterade endometrios 
och endometriosrelaterade frågor med endometriosdiagnos i slutenvårdsregistret (Studie III)  
bland svenska kvinnliga tvillingar. Studiepopulationen utgjordes av  alla kvinnliga tvillingar i 
svenska tvillingregistret, i åldern 20-65 år i Studie I och II och i åldern 20-60 år i Studie III.  
Prevalensen av endometrios bland svenska tvillingar uppskattades vara 4,3%. Ärftligheten av 
endometrios förklaras med 47% och resten av effekten förklaras av miljöfaktorer. Högre 
ålder vid menarche och högre paritet med två eller fler barn medförde lägre risk att 
diagnostiseras med endometrios, medan infertilitet hade ett starkt positivt samband med 
endometrios. Användning av p-piller enbart som preventivmedel visade  inget signifikant 
samband med endometrios. Faktorer som BMI, utbildningsnivå och andra livsstilsfaktorer 
som kaffe, rökning och alkohol visade heller inte signifikant samband med endometrios. God 
överensstämmelse fanns mellan självrapporterade endometrios och endometriosdata i 
slutenvårdsregistret och sannolikheten att förutsäga en endometriosdiagnos i 
slutenvårdsregistret ökade när det också fanns information om ålder och infertilitet. 
Sammanfattningsvis, resultaten från studierna i denna avhandling tyder på stark genetisk 
inverkan på utvecklingen av endometrios. Infertilitet och endometrios är starkt associerade  
till varandra, men inget kausalsamband har kunnat påvisas. Studierna har också visat att 
enkäter med endometriosspecifika frågor förefaller vara ett tillförlitligt instrument i kliniska 
och epidemiologiska studier.  
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